Skip to main content

and
  1. No Access

    Article

    Detecting dic(9;20)(p13.2;p11.2)-positive B-cell precursor acute lymphoblastic leukemia in a clinical setting using fluorescence in situ hybridization

    V Zachariadis, J Schoumans, I Öfverholm, G Barbany, E Halvardsson, E Forestier in Leukemia (2014)

  2. No Access

    Article

    Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols

    I Öfverholm, A N Tran, M Heyman, V Zachariadis, M Nordenskjöld, A Nordgren in Leukemia (2013)

  3. No Access

    Article

    The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial

    The dic(9;20)(p13.2;q11.2) is reported to be present in ∼2% of childhood B-cell precursor acute lymphoblastic leukemia (BCP ALL). However, it easily escapes detection by G-banding analysis and its true prevale...

    V Zachariadis, F Gauffin, E Kuchinskaya, M Heyman, J Schoumans, E Blennow in Leukemia (2011)